Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Galmed Pharmaceuticals Ltd (NASDAQ:GLMD)

9.59
Delayed Data
As of 10:03am ET
 -0.25 / -2.54%
Today’s Change
4.58
Today|||52-Week Range
13.50
+65.34%
Year-to-Date

Today’s Trading

Previous close9.84
Today’s open9.81
Day’s range9.52 - 9.81
Volume9,824
Average volume (3 months)36,490
Market cap$111.4M
Dividend yield--
Data as of 10:03am ET, 07/30/2015

Growth & Valuation

Earnings growth (last year)-125.51%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratio--
Price/Sales--
Price/Book3.55

Competitors

 Today’s
change
Today’s
% change
REPHRecro Pharma Inc-0.34-2.58%
CERUCerulean Pharma Inc-0.06-1.46%
ARQLArQule Inc-0.05-2.94%
JNPJuniper Pharmaceutic...-0.08-0.82%
Data as of 10:05am ET, 07/30/2015

Financials

Last reporting dateJuly 30, 2015
EPS forecast (this quarter)-$0.25
Annual revenue (last year)$0.00
Annual profit (last year)-$9.1M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Allen Baharaff
Chief Financial Officer
Josh Blacher
Corporate headquarters
Tel Aviv, Tel Aviv

Forecasts